GlaxoSmithKline Plc (Mexico) Buy Hold or Sell Recommendation
| GSKN Stock | MXN 655.00 0.00 0.00% |
Assuming the 90 days trading horizon and your typical level of risk aversion, our recommendation regarding GlaxoSmithKline plc is 'Strong Hold'. Macroaxis provides GlaxoSmithKline Plc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GSKN positions. The advice algorithm takes into account all of GlaxoSmithKline Plc's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting GlaxoSmithKline Plc's buy or sell advice are summarized below:
Real Value 668 | Hype Value 655 | Market Value 655 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell GlaxoSmithKline plc given historical horizon and risk tolerance towards GlaxoSmithKline Plc. When Macroaxis issues a 'buy' or 'sell' recommendation for GlaxoSmithKline plc, the advice is generated through an automated system that utilizes algorithms and statistical models.
GlaxoSmithKline |
Execute GlaxoSmithKline Plc Buy or Sell Advice
The GlaxoSmithKline recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on GlaxoSmithKline plc. Macroaxis does not own or have any residual interests in GlaxoSmithKline plc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute GlaxoSmithKline Plc's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
GlaxoSmithKline Plc Trading Alerts and Improvement Suggestions
| GlaxoSmithKline plc generated a negative expected return over the last 90 days |
GlaxoSmithKline Plc Returns Distribution Density
The distribution of GlaxoSmithKline Plc's historical returns is an attempt to chart the uncertainty of GlaxoSmithKline Plc's future price movements. The chart of the probability distribution of GlaxoSmithKline Plc daily returns describes the distribution of returns around its average expected value. We use GlaxoSmithKline plc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of GlaxoSmithKline Plc returns is essential to provide solid investment advice for GlaxoSmithKline Plc.
| Mean Return | -0.04 | Value At Risk | 0.00 | Potential Upside | 0.24 | Standard Deviation | 1.01 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GlaxoSmithKline Plc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
GlaxoSmithKline Plc Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to GlaxoSmithKline Plc or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that GlaxoSmithKline Plc's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a GlaxoSmithKline stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.08 | |
β | Beta against NYSE Composite | 0.37 | |
σ | Overall volatility | 1.06 | |
Ir | Information ratio | -0.13 |
GlaxoSmithKline Plc Volatility Alert
GlaxoSmithKline plc exhibits very low volatility with skewness of -5.5 and kurtosis of 45.41. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure GlaxoSmithKline Plc's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact GlaxoSmithKline Plc's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.GlaxoSmithKline Plc Fundamentals Vs Peers
Comparing GlaxoSmithKline Plc's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze GlaxoSmithKline Plc's direct or indirect competition across all of the common fundamentals between GlaxoSmithKline Plc and the related equities. This way, we can detect undervalued stocks with similar characteristics as GlaxoSmithKline Plc or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of GlaxoSmithKline Plc's fundamental indicators could also be used in its relative valuation, which is a method of valuing GlaxoSmithKline Plc by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare GlaxoSmithKline Plc to competition |
| Fundamentals | GlaxoSmithKline Plc | Peer Average |
| Return On Equity | 0.31 | -0.31 |
| Return On Asset | 0.0659 | -0.14 |
| Profit Margin | 0.51 % | (1.27) % |
| Operating Margin | 0.25 % | (5.51) % |
| Current Valuation | 1.79 T | 16.62 B |
| Shares Outstanding | 2.05 B | 571.82 M |
| Shares Owned By Insiders | 0.02 % | 10.09 % |
| Shares Owned By Institutions | 14.10 % | 39.21 % |
| Price To Earning | 11.33 X | 28.72 X |
| Price To Book | 6.05 X | 9.51 X |
| Price To Sales | 37.65 X | 11.42 X |
| Revenue | 29.32 B | 9.43 B |
| Gross Profit | 19.92 B | 27.38 B |
| EBITDA | 8.8 B | 3.9 B |
| Net Income | 14.96 B | 570.98 M |
| Cash And Equivalents | 6.53 B | 2.7 B |
| Cash Per Share | 0.32 X | 5.01 X |
| Total Debt | 19.76 B | 5.32 B |
| Debt To Equity | 0.98 % | 48.70 % |
| Current Ratio | 1.43 X | 2.16 X |
| Book Value Per Share | 5.25 X | 1.93 K |
| Cash Flow From Operations | 7.4 B | 971.22 M |
| Earnings Per Share | 49.71 X | 3.12 X |
| Price To Earnings To Growth | 1.04 X | 4.89 X |
| Number Of Employees | 45 | 18.84 K |
| Beta | 0.28 | -0.15 |
| Market Capitalization | 1.38 T | 19.03 B |
| Total Asset | 60.15 B | 29.47 B |
| Retained Earnings | (3.7 B) | 9.33 B |
| Working Capital | 1.91 B | 1.48 B |
| Current Asset | 15.83 B | 9.34 B |
| Current Liabilities | 13.92 B | 7.9 B |
| Z Score | 41.4 | 8.72 |
GlaxoSmithKline Plc Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as GlaxoSmithKline . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About GlaxoSmithKline Plc Buy or Sell Advice
When is the right time to buy or sell GlaxoSmithKline plc? Buying financial instruments such as GlaxoSmithKline Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having GlaxoSmithKline Plc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Outsourcing Thematic Idea Now
Outsourcing
Companies involved in providing outsourcing and staffing services to business across different domains. The Outsourcing theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Outsourcing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out GlaxoSmithKline Plc Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for GlaxoSmithKline Stock analysis
When running GlaxoSmithKline Plc's price analysis, check to measure GlaxoSmithKline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline Plc is operating at the current time. Most of GlaxoSmithKline Plc's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline Plc's price. Additionally, you may evaluate how the addition of GlaxoSmithKline Plc to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |